Prevalence and duration of loss of smell and taste among COVID-19 affected dentists

2021 ◽  
Vol 15 (9) ◽  
pp. 2470-2473
Author(s):  
Muhammad Bilal Arshad ◽  
Ehsan Rathore ◽  
Muhammad Behzad Salahuddin ◽  
Asadullah Rathore ◽  
Waleed Javaid Toosy ◽  
...  
Keyword(s):  
Early Stage ◽  
Recovery Period ◽  
Cross Sectional Study ◽  
Sensory Loss ◽  
Temporal Development ◽  
Sectional Study ◽  
Cross Sectional ◽  
Detailed Evaluation ◽  
Important Symptom ◽  
Taste And Smell

Objectives: This study was aimed to look into the prevalence of Sensory loss of Smell and taste among dentists and dental faculty affected with COVID-19 during the current pandemic. Methods: This cross sectional study was conducted in August, 2021, carrying out detailed evaluation of onset, temporal development and resolution of loss of taste and smell among 207 COVID-19 patients with confirmatory PCR lab reports. Clinical and epidemiological variables of COVID-19 symptoms were studied that included age categories, gender, onset and resolution of loss of taste and smell as compared with other symptoms. This study also included altered taste aspect experienced by the COVID-19 affected dentists. Results: Of 207 previous patients of COVID-19, 168 (81%) reported that they experienced loss of smell and/or loss of taste during the ailment. Of these 168, 151 (89.88%) patients experienced both loss of taste and smell while 17 (10.11%) reported to have been afflicted with isolated loss of smell or isolated loss of taste. Among 114 (67.85%) patients, Onset of loss of smell and taste was reported to be occurring at the same time along with other symptoms. A vast majority of the patients 141 (89.24%) also reported altered taste associated with recovery period of COVID-19. Conclusion: Sensory loss of smell and taste should be regarded as important symptom at the very early stage of COVID-19 and patients should take isolation measures upon appearing of these symptoms. Key Words: Anosmia, Hyposmia, COVID-19, Dysgeusia

scholarly journals Effect of number of medications and use of potentially inappropriate medications on frailty among early-stage older outpatients

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Yuya Uragami ◽  
Kazuhiro Takikawa ◽  
Hajime Kareki ◽  
Koji Kimura ◽  
Kazuyuki Yamamoto ◽  
...  
Keyword(s):  
Early Stage ◽  
Linear Trend ◽  
Cross Sectional Study ◽  
Potentially Inappropriate Medications ◽  
Sectional Study ◽  
Antithrombotic Drugs ◽  
Cross Sectional ◽  
The Relationship ◽  
Inappropriate Medications ◽  
Frailty Score

Abstract Background Frailty is an urgent concern among an aging population worldwide. However, the relationship between frailty and number and types of medications has not been studied in detail among early-stage older patients, and it is unclear what prescriptions may have a role in preventing frailty. This study aimed to clarify the effects of number of medications and use of potentially inappropriate medications (PIMs) on frailty among early-stage older outpatients in Japan. Methods A cross-sectional study was undertaken. Frailty scores and medications of outpatients aged 65–74 years who regularly visited community pharmacies were investigated. Frailty scores were classified as 0 (non-frailty), 1–2 (pre-frailty), and ≥ 3 (frailty). The association between frailty and number of medications was analyzed by age and compared between PIM use and non-use groups. The proportion of patients who used PIMs was also analyzed by frailty score. Results Of 923 older outpatients, 49 (5.3%) and 318 (34.5%) patients had frailty and pre-frailty scores, respectively. The numbers of medications among patients with pre-frailty and frailty were significantly higher than among those with non-frailty (p <  0.001 for both). A similar increase was shown for PIM use groups aged 69–71 and 72–74 years, but not for the PIM use group aged 65–68 years and all groups without PIM use. An increasing linear trend was observed for the relationship between the proportion of patients who used any PIM, as well as some subcategories of PIMs (such as NSAIDs, benzodiazepines, loop diuretics and antithrombotic drugs) and frailty score. Conclusions Unnecessary medication use among early-stage older outpatients, especially patients aged ≥69 years who use PIMs and many medications, seems to be associated with frailty, but further research is needed to confirm these findings.

scholarly journals Role of Age and Sex in the Diagnosis of Early-stage Malignant Melanoma: A Cross-Sectional study

2015 ◽  
Vol 95 (8) ◽  
pp. 940-942 ◽  
Author(s):  
D Moreno-Ramírez ◽  
T Ojeda-Vila ◽  
J Ríos-Martín ◽  
A Nieto-García ◽  
L Ferrándiz
Keyword(s):  
Malignant Melanoma ◽  
Early Stage ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Age And Sex

Requests for Health Education from Chinese Cancer Patients During Their Recovery Period: a Cross-Sectional Study

2013 ◽  
Vol 28 (3) ◽  
pp. 428-434 ◽  
Author(s):  
Wei-Li Qiu ◽  
Pei-Juan Lin ◽  
Fei-Qun Ruan ◽  
Xiao Wu ◽  
Miao-Ping Lin ◽  
...  
Keyword(s):  
Health Education ◽  
Cancer Patients ◽  
Recovery Period ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Chinese Cancer Patients

scholarly journals Anxiety Among Inpatients With Cancer: Findings From a Hospital-Based Cross-Sectional Study in Vietnam

2019 ◽  
Vol 26 (1) ◽  
pp. 107327481986464 ◽  
Author(s):  
Dung Viet Truong ◽  
Quyen Thi Tu Bui ◽  
Do Tri Nguyen ◽  
Jaleesa Moore
Keyword(s):  
Health Workers ◽  
Early Stage ◽  
Cross Sectional Study ◽  
Anxiety Score ◽  
Medical Mistrust ◽  
Sectional Study ◽  
Related Factors ◽  
Cross Sectional ◽  
Patients With Cancer ◽  
Patient Health

Anxiety, a condition which is commonly found in patients with cancer, has negative impacts on their quality of life and treatment outcome. This study aimed to determine the level of anxiety in patients with cancer and explore sociodemographic, disease-related, and hospital-related factors associated with anxiety in those patients. A cross-sectional study was conducted on 510 inpatients with cancer at Thanh Hoa Oncology Hospital, Vietnam. Data were collected from self-administered questionnaire forms on hospital depression anxiety-A, interviews with patients, and patient medical records. The univariate and multivariate linear regression analyses were performed using STATA ver. 14.0. Our finding that the patients’ mean anxiety score (standard deviation) was 7.22 (3.8); 27.6% of the patients had an anxiety score between 8 and 10 points, and 15.5% had an anxiety score of ≥11 points. In the multivariate model, in more advanced stages of cancer, and patients with metastasis were more likely to have higher levels of anxiety than those who presented no sign of metastasis. The longer the patients had cancer, the less anxious they became. Lower levels of anxiety were observed in patients who stated that hospital facilities were adequate or had trust in health workers. Patients with cancer need to be provided with psychological support in the early stage of cancer detection and when metastases form. A strong patient–health-care provider relationship after diagnosis may help reduce distress among patients with cancer with higher levels of medical mistrust.

Sign in / Sign up

Export Citation Format

Share Document